|
⚲
|
| Keyboard |
| Andrew Ritter | |
|---|---|
| Firm | |
| Address | 505 Montgomery Street 10th Floor San Francisco, CA 94111 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| GT Biopharma Inc | 021-547407 | Director | of 20.0 M |
||
| GT Biopharma Inc | 021-547250 | Director | 6.0 M of 6.0 M |
||
| Myosin Therapeutics Inc | 021-467831 | Director | 3.0 M of 3.0 M |
||
| Ritter Pharmaceuticals Inc | 021-325440 | Executive Officer | 6.0 M of 6.0 M |
||
| Ritter Pharmaceuticals Inc | 021-230217 | Executive Officer | 3.7 M of 5.7 M |
||
| Ritter Pharmaceuticals Inc | 021-173889 | Executive Officer | 0.5 M of 3.5 M |
||
| Ritter Pharmaceuticals Inc | 021-151134 | Executive Officer | 7.4 M of 7.4 M |
||
| Ritter Pharmaceuticals Inc | 021-148870 | Executive Officer | 0.2 M of 0.2 M |
||
| Ritter Pharmaceuticals Inc | 021-129557 | Executive Officer | 0.5 M of 0.5 M |
||